[English] 日本語
Yorodumi- EMDB-70926: Cryo-EM structure of human PRMT5:MEP50 in complex with SAH and co... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Cryo-EM structure of human PRMT5:MEP50 in complex with SAH and compounds 16-19F and HJL-1 | |||||||||
Map data | ||||||||||
Sample |
| |||||||||
Keywords | arginine methyltransferase / TRANSFERASE | |||||||||
| Function / homology | Function and homology informationpositive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway / peptidyl-arginine N-methylation / type II protein arginine methyltransferase / protein-arginine omega-N symmetric methyltransferase activity / Golgi ribbon formation / histone H4R3 methyltransferase activity / protein-arginine N-methyltransferase activity / positive regulation of mRNA splicing, via spliceosome / methylosome / positive regulation of rRNA processing ...positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway / peptidyl-arginine N-methylation / type II protein arginine methyltransferase / protein-arginine omega-N symmetric methyltransferase activity / Golgi ribbon formation / histone H4R3 methyltransferase activity / protein-arginine N-methyltransferase activity / positive regulation of mRNA splicing, via spliceosome / methylosome / positive regulation of rRNA processing / methyl-CpG binding / endothelial cell activation / histone H3 methyltransferase activity / regulation of mitotic nuclear division / histone methyltransferase activity / positive regulation of oligodendrocyte differentiation / negative regulation of gene expression via chromosomal CpG island methylation / negative regulation of cGAS/STING signaling pathway / E-box binding / histone methyltransferase complex / Cul4B-RING E3 ubiquitin ligase complex / negative regulation of cell differentiation / regulation of ERK1 and ERK2 cascade / liver regeneration / ribonucleoprotein complex binding / ubiquitin-like ligase-substrate adaptor activity / spliceosomal snRNP assembly / methyltransferase activity / regulation of signal transduction by p53 class mediator / circadian regulation of gene expression / DNA-templated transcription termination / Regulation of TP53 Activity through Methylation / cellular response to growth factor stimulus / protein polyubiquitination / RMTs methylate histone arginines / p53 binding / transcription corepressor activity / snRNP Assembly / ubiquitin-dependent protein catabolic process / transcription coactivator activity / chromosome / chromatin remodeling / protein heterodimerization activity / regulation of DNA-templated transcription / chromatin / Golgi apparatus / nucleoplasm / identical protein binding / nucleus / cytosol / cytoplasm Similarity search - Function | |||||||||
| Biological species | Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.1 Å | |||||||||
Authors | Xu X / Chi Z / Jiang W / Li C | |||||||||
| Funding support | United States, 1 items
| |||||||||
Citation | Journal: J Enzyme Inhib Med Chem / Year: 2026Title: Cryo-EM structure-based discovery of etravirine as a specific inhibitor of PRMT5/pICln protein-protein interaction for prostate cancer treatment. Authors: Zhixia Chi / Xueyong Xu / Zhihang Shen / Xuehong Deng / Bennett D Elzey / Chenglong Li / Wen Jiang / Chang-Deng Hu / ![]() Abstract: Protein arginine methyltransferase 5 (PRMT5) is overexpressed in many cancers and correlates with poor patient survival. In prostate cancer, PRMT5 cooperates with its cofactor pICln to promote tumour ...Protein arginine methyltransferase 5 (PRMT5) is overexpressed in many cancers and correlates with poor patient survival. In prostate cancer, PRMT5 cooperates with its cofactor pICln to promote tumour growth by epigenetically activating androgen receptor (AR) expression. Using a near-atomic cryo-EM structure of PRMT5/MEP50/pICln complex, we identified a previously undefined, pICln-specific protein-protein interaction (PPI) interface on PRMT5, termed P4I. Structure-based virtual screening identified the FDA-approved compound etravirine as a binder to this site. BiFC, Co-IP, and PLA assays confirmed that etravirine disrupts PRMT5/pICln interaction. A cryo-EM structure of PRMT5/MEP50/etravirine further validated on-target binding at P4I. Functionally, etravirine reduced prostate cancer cell proliferation, inhibited tumour growth, and downregulated AR and AR-V7 expression in cells and in mouse models. These results demonstrate that the unique P4I interface is a promising therapeutic target and that etravirine serves as a proof-of-concept lead compound for exploring the potential of P4I-targeted strategies in prostate cancer. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_70926.map.gz | 122 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-70926-v30.xml emd-70926.xml | 21.7 KB 21.7 KB | Display Display | EMDB header |
| Images | emd_70926.png | 167.7 KB | ||
| Filedesc metadata | emd-70926.cif.gz | 6.9 KB | ||
| Others | emd_70926_half_map_1.map.gz emd_70926_half_map_2.map.gz | 226.8 MB 226.8 MB | ||
| Archive directory | https://data.pdbj.org/pub/emdb/structures/EMD-70926 ftp://data.pdbj.org/pub/emdb/structures/EMD-70926 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9ovyMC ![]() 9z49C ![]() 9z4aC M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_70926.map.gz / Format: CCP4 / Size: 244.1 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.822 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: #2
| File | emd_70926_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #1
| File | emd_70926_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Cryo-EM structure of human PRMT5:MEP50 in complex with SAH and co...
| Entire | Name: Cryo-EM structure of human PRMT5:MEP50 in complex with SAH and compounds 16-19F and HJL-1 |
|---|---|
| Components |
|
-Supramolecule #1: Cryo-EM structure of human PRMT5:MEP50 in complex with SAH and co...
| Supramolecule | Name: Cryo-EM structure of human PRMT5:MEP50 in complex with SAH and compounds 16-19F and HJL-1 type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#2 |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
-Macromolecule #1: Protein arginine N-methyltransferase 5
| Macromolecule | Name: Protein arginine N-methyltransferase 5 / type: protein_or_peptide / ID: 1 / Number of copies: 4 / Enantiomer: LEVO / EC number: type II protein arginine methyltransferase |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 72.766664 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: MAAMAVGGAG GSRVSSGRDL NCVPEIADTL GAVAKQGFDF LCMPVFHPRF KREFIQEPAK NRPGPQTRSD LLLSGRDWNT LIVGKLSPW IRPDSKVEKI RRNSEAAMLQ ELNFGAYLGL PAFLLPLNQE DNTNLARVLT NHIHTGHHSS MFWMRVPLVA P EDLRDDII ...String: MAAMAVGGAG GSRVSSGRDL NCVPEIADTL GAVAKQGFDF LCMPVFHPRF KREFIQEPAK NRPGPQTRSD LLLSGRDWNT LIVGKLSPW IRPDSKVEKI RRNSEAAMLQ ELNFGAYLGL PAFLLPLNQE DNTNLARVLT NHIHTGHHSS MFWMRVPLVA P EDLRDDII ENAPTTHTEE YSGEEKTWMW WHNFRTLCDY SKRIAVALEI GADLPSNHVI DRWLGEPIKA AILPTSIFLT NK KGFPVLS KMHQRLIFRL LKLEVQFIIT GTNHHSEKEF CSYLQYLEYL SQNRPPPNAY ELFAKGYEDY LQSPLQPLMD NLE SQTYEV FEKDPIKYSQ YQQAIYKCLL DRVPEEEKDT NVQVLMVLGA GRGPLVNASL RAAKQADRRI KLYAVEKNPN AVVT LENWQ FEEWGSQVTV VSSDMREWVA PEKADIIVSE LLGSFADNEL SPECLDGAQH FLKDDGVSIP GEYTSFLAPI SSSKL YNEV RACREKDRDP EAQFEMPYVV RLHNFHQLSA PQPCFTFSHP NRDPMIDNNR YCTLEFPVEV NTVLHGFAGY FETVLY QDI TLSIRPETHS PGMFSWFPIL FPIKQPITVR EGQTICVRFW RCSNSKKVWY EWAVTAPVCS AIHNPTGRSY TIGL UniProtKB: Protein arginine N-methyltransferase 5 |
-Macromolecule #2: Methylosome protein 50
| Macromolecule | Name: Methylosome protein 50 / type: protein_or_peptide / ID: 2 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 36.757246 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: MRKETPPPLV PPAAREWNLP PNAPACMERQ LEAARYRSDG ALLLGASSLS GRCWAGSLWL FKDPCAAPNE GFCSAGVQTE AGVADLTWV GERGILVASD SGAVELWELD ENETLIVSKF CKYEHDDIVS TVSVLSSGTQ AVSGSKDICI KVWDLAQQVV L SSYRAHAA ...String: MRKETPPPLV PPAAREWNLP PNAPACMERQ LEAARYRSDG ALLLGASSLS GRCWAGSLWL FKDPCAAPNE GFCSAGVQTE AGVADLTWV GERGILVASD SGAVELWELD ENETLIVSKF CKYEHDDIVS TVSVLSSGTQ AVSGSKDICI KVWDLAQQVV L SSYRAHAA QVTCVAASPH KDSVFLSCSE DNRILLWDTR CPKPASQIGC SAPGYLPTSL AWHPQQSEVF VFGDENGTVS LV DTKSTSC VLSSAVHSQC VTGLVFSPHS VPFLASLSED CSLAVLDSSL SELFRSQAHR DFVRDATWSP LNHSLLTTVG WDH QVVHHV VPTEPLPAPG PASVTE UniProtKB: Methylosome protein WDR77 |
-Macromolecule #3: Etravirine
| Macromolecule | Name: Etravirine / type: ligand / ID: 3 / Number of copies: 4 / Formula: 65B |
|---|---|
| Molecular weight | Theoretical: 435.277 Da |
-Macromolecule #4: S-ADENOSYL-L-HOMOCYSTEINE
| Macromolecule | Name: S-ADENOSYL-L-HOMOCYSTEINE / type: ligand / ID: 4 / Number of copies: 4 / Formula: SAH |
|---|---|
| Molecular weight | Theoretical: 384.411 Da |
| Chemical component information | ![]() ChemComp-SAH: |
-Macromolecule #5: 8-chloro-1-[(2,4-diaminoquinazolin-7-yl)methyl]-3,4-dihydroquinol...
| Macromolecule | Name: 8-chloro-1-[(2,4-diaminoquinazolin-7-yl)methyl]-3,4-dihydroquinolin-2(1H)-one type: ligand / ID: 5 / Number of copies: 4 / Formula: A1CEU |
|---|---|
| Molecular weight | Theoretical: 353.806 Da |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 7.5 |
|---|---|
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Average electron dose: 54.44 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 0.6 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
United States, 1 items
Citation





Z (Sec.)
Y (Row.)
X (Col.)






































Processing
FIELD EMISSION GUN

